RT Journal Article
SR Electronic
T1 The predictors of new-onset atrial fibrillation incidence after on-pump coronary artery bypass graft surgery: A prospective study evaluating syntax score
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.21.23286217
DO 10.1101/2023.02.21.23286217
A1 Mombeini, Hoda
A1 Ebrahimi, Alireza
A1 Yazdankhah, Saeed
A1 Sheikhi, Mohammad Ali
A1 Majidi, Shahla
A1 Pakdin, Majid
YR 2023
UL http://medrxiv.org/content/early/2023/02/24/2023.02.21.23286217.abstract
AB Background Atrial fibrillation (AF) is considered the most common supraventricular arrhythmia in patients undergoing coronary artery bypass graft (CABG). The predictive value of the SYNTAX score for post-CABG new-onset AF incidence has not been clearly evaluated. This study aimed to assess this association in patients undergoing isolated on-pump CABG.Method This study was done in a single-center, randomized, and observational setting. A total of 133 patients undergoing on-pump isolated CABG who were older than 18 years and had sinus rhythm were enrolled. Demographic variables of patients were recorded, and the SYNTAX score was measured for the participants. The multivariate logistic regression model was applied to identify the predictors of post-CABG new-onset AF.Results The logistic regression model showed that SYNTAX score of more than 28.25 (p-value= 0.001; OR= 14.25, 95% CI= 2.90_70.11), hypertension (p-value=0.02; OR = 6.59, 95% CI = 1.23_34.57), and calcium channel blocker consumption (p-value=0.02; OR = 8.05, 95% CI = 1.43_45.42) are predictors of new-onset AF after on-pump CABG.Conclusion This study demonstrated that patients with higher SYNTAX scores in coronary angiography are more likely to develop new-onset AF after isolated on-pump CABG.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors did not receive any funding support for the investigation and authorship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Ahvaz Jundishapur University of Medical Sciences gave ethical approval for this work (Reg. No. IR.AJUMS.REC.1394.91).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.